Insurance scare tactics are obscuring ObamaCare's benefits

Pharmaceutical firms are getting their money's worth on Capitol Hill

A new federal report urges enhanced research into potential environmental triggers of breast cancer.

Are feds doing all they can to ferret out waste from move to electronic records?

Part D brought drug companies billions, but they say the sky is falling

Employers, insurers see high-deductible health plans as wave of the future.